Company Bioxytran Inc OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
19/04 | Bioxytran, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
19/04 | Bioxytran, Inc. Announces Board Changes | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Platt
CEO | Chief Executive Officer | 71 | 01/18/01 |
Ola Soderquist
DFI | Director of Finance/CFO | 63 | - |
Leslie Ajayi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Sheikh
IRO | Public Communications Contact | 54 | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Platt
CEO | Chief Executive Officer | 71 | 01/18/01 |
Dale Conaway
BRD | Director/Board Member | 69 | 02/18/02 |
Anders Utter
BRD | Director/Board Member | 57 | 02/18/02 |
Alan Hoberman
BRD | Director/Board Member | 71 | 02/18/02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 174,962,481 | 75,447,287 ( 43.12 %) | 0 | 43.12 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+5.66% | 11TCr | |
+11.23% | 11TCr | |
-0.38% | 2.23TCr | |
-12.15% | 2.21TCr | |
-7.66% | 1.87TCr | |
-36.52% | 1.76TCr | |
-10.09% | 1.69TCr | |
+3.33% | 1.38TCr | |
+36.58% | 1.25TCr |
- Stock Market
- Equities
- BIXT Stock
- Stock
- Company Bioxytran Inc